Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro
- 1 December 1985
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 23 (6) , 875-881
- https://doi.org/10.1016/0022-4731(85)90042-1
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Theory and experimental method for determining individual kinetic constants of fast-acting, irreversible proteinase inhibitorsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1984
- Characterization of the Estrogen Receptor and Its Dynamics in MCF-7 Human Breast Cancer Cells Using a Covalently Attaching Antiestrogen*Endocrinology, 1984
- Affinity Labeling of Receptors for Steroid and Thyroid HormonesPublished by Elsevier ,1984
- Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifenThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- TAMOXIFEN AZIRIDINES: EFFECTIVE INACTIVATORS OF THE ESTROGEN RECEPTOREndocrinology, 1981
- A quantitative assay for the activation of plasminogen by transformed cells in situ and by urokinaseBiochemistry, 1981
- Dynamics of Steroid Hormone Receptor ActionAnnual Review of Physiology, 1980
- Estrogen Control of Progesterone Receptor in Human Breast Cancer: Role of Estradiol and Antiestrogen*Endocrinology, 1978
- Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.BMJ, 1975
- Antioestrogens in Treatment of Breast Cancer: Value of Nafoxidine in 52 Advanced CasesBMJ, 1974